Blue Chip Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Blue Chip Partners's VRTX Position: Q1 2026 in Review
Blue Chip Partners increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q1 2026, buying an estimated $95.1K and bringing the position to 1,895 shares worth $846K. The position accounts for 0.06% of the portfolio, ranked #96.
Blue Chip Partners first reported a position in VRTX in Q2 2024 and has held it in 7 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Blue Chip Partners held 1,895 shares of Vertex Pharmaceuticals worth $846K as of Q1 2026.
- Blue Chip Partners bought 204 Vertex Pharmaceuticals shares in Q1 2026, an estimated $95.1K.
- Vertex Pharmaceuticals made up 0.06% of Blue Chip Partners's portfolio in Q1 2026, its #96 holding.
- Blue Chip Partners first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Blue Chip Partners's 13F filing for Q1 2026, filed 15 May 2026.